AI health company Pangaea Data today launched its next-generation platform, designed to help clinicians - Read more from ...

This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Background The development of non-sputum-based tests is an urgent priority to increase access to tuberculosis (TB) diagnostic ...

Serving approximately 3,000 customers across 12 facilities in the United States, Mexio, Asia and Europe, Nelson Labs is a global leader in outsourced microbiological and analytical chemistry testing ...

AI has the potential to transform NHS and social care services, but can providers adopt AI at the pace and scale needed to ...

Good afternoon, and welcome to the NVE Corporation Conference Call for the quarter ended September 30, 2025. The I'm Dan Baker, NVE's President and CEO. I'm joined by Daniel Nelson, our Principal ...

Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...